+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cell Dissociation - Global Market Trajectory & Analytics

  • ID: 4804664
  • Report
  • April 2021
  • Region: Global
  • 176 pages
  • Global Industry Analysts, Inc
Global Cell Dissociation Market to Reach $546 Million by 2027

Amid the COVID-19 crisis, the global market for Cell Dissociation estimated at US$245.2 Million in the year 2020, is projected to reach a revised size of US$546 Million by 2027, growing at a CAGR of 12.1% over the analysis period 2020-2027. Enzymatic Dissociation Products, one of the segments analyzed in the report, is projected to record a 12.8% CAGR and reach US$277.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-enzymatic Dissociation Products segment is readjusted to a revised 11.8% CAGR for the next 7-year period.



The U.S. Market is Estimated at $72.4 Million, While China is Forecast to Grow at 11.6% CAGR

The Cell Dissociation market in the U.S. is estimated at US$72.4 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$95.3 Million by the year 2027 trailing a CAGR of 11.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.7% and 10.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.8% CAGR.

Instruments & Accessories Segment to Record 10.9% CAGR

In the global Instruments & Accessories segment, USA, Canada, Japan, China and Europe will drive the 10.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$37.1 Million in the year 2020 will reach a projected size of US$75.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$64.4 Million by the year 2027.

Select Competitors (Total 44 Featured):
  • American Type Culture Collection (ATCC)
  • Becton, Dickinson & Company
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HiMedia Laboratories
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • PAN-Biotech GmbH
  • StemCell Technologies Inc.
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Table 1: World Current & Future Analysis for Cell Dissociation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Cell Dissociation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Enzymatic Dissociation Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Enzymatic Dissociation Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Non-enzymatic Dissociation Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Non-enzymatic Dissociation Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Instruments & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Instruments & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Connective Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Connective Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Epithelial Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Epithelial Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 13: World Current & Future Analysis for Other Tissue by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 14: World 7-Year Perspective for Other Tissue by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 15: World Current & Future Analysis for Pharmaceutical & Biotechnological Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 16: World 7-Year Perspective for Pharmaceutical & Biotechnological Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 17: World Current & Future Analysis for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 18: World 7-Year Perspective for Research & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 19: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 20: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS
  • Table 21: USA Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 22: USA 7-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2020 & 2027
  • Table 23: USA Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissue - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 24: USA 7-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissue for the Years 2020 & 2027
  • Table 25: USA Current & Future Analysis for Cell Dissociation by End-Use - Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: USA 7-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses for the Years 2020 & 2027
  • Table 27: Canada Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 28: Canada 7-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2020 & 2027
  • Table 29: Canada Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissue - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 30: Canada 7-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissue for the Years 2020 & 2027
  • Table 31: Canada Current & Future Analysis for Cell Dissociation by End-Use - Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Canada 7-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses for the Years 2020 & 2027
  • Table 33: Japan Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 34: Japan 7-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2020 & 2027
  • Table 35: Japan Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissue - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 36: Japan 7-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissue for the Years 2020 & 2027
  • Table 37: Japan Current & Future Analysis for Cell Dissociation by End-Use - Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: Japan 7-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses for the Years 2020 & 2027
  • Table 39: China Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 40: China 7-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2020 & 2027
  • Table 41: China Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissue - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 42: China 7-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissue for the Years 2020 & 2027
  • Table 43: China Current & Future Analysis for Cell Dissociation by End-Use - Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 44: China 7-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses for the Years 2020 & 2027
  • Table 45: Europe Current & Future Analysis for Cell Dissociation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 46: Europe 7-Year Perspective for Cell Dissociation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 47: Europe Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 48: Europe 7-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2020 & 2027
  • Table 49: Europe Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissue - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 50: Europe 7-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissue for the Years 2020 & 2027
  • Table 51: Europe Current & Future Analysis for Cell Dissociation by End-Use - Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 52: Europe 7-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses for the Years 2020 & 2027
  • Table 53: France Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 54: France 7-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2020 & 2027
  • Table 55: France Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissue - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 56: France 7-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissue for the Years 2020 & 2027
  • Table 57: France Current & Future Analysis for Cell Dissociation by End-Use - Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 58: France 7-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses for the Years 2020 & 2027
  • Table 59: Germany Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 60: Germany 7-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2020 & 2027
  • Table 61: Germany Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissue - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 62: Germany 7-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissue for the Years 2020 & 2027
  • Table 63: Germany Current & Future Analysis for Cell Dissociation by End-Use - Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 64: Germany 7-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses for the Years 2020 & 2027
  • Table 65: Italy Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 66: Italy 7-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2020 & 2027
  • Table 67: Italy Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissue - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 68: Italy 7-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissue for the Years 2020 & 2027
  • Table 69: Italy Current & Future Analysis for Cell Dissociation by End-Use - Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 70: Italy 7-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses for the Years 2020 & 2027
  • Table 71: UK Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 72: UK 7-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2020 & 2027
  • Table 73: UK Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissue - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 74: UK 7-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissue for the Years 2020 & 2027
  • Table 75: UK Current & Future Analysis for Cell Dissociation by End-Use - Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 76: UK 7-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses for the Years 2020 & 2027
  • Table 77: Rest of Europe Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 78: Rest of Europe 7-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2020 & 2027
  • Table 79: Rest of Europe Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissue - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 80: Rest of Europe 7-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissue for the Years 2020 & 2027
  • Table 81: Rest of Europe Current & Future Analysis for Cell Dissociation by End-Use - Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 82: Rest of Europe 7-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses for the Years 2020 & 2027
  • Table 83: Asia-Pacific Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 84: Asia-Pacific 7-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2020 & 2027
  • Table 85: Asia-Pacific Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissue - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 86: Asia-Pacific 7-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissue for the Years 2020 & 2027
  • Table 87: Asia-Pacific Current & Future Analysis for Cell Dissociation by End-Use - Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 88: Asia-Pacific 7-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses for the Years 2020 & 2027
  • Table 89: Rest of World Current & Future Analysis for Cell Dissociation by Product Type - Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 90: Rest of World 7-Year Perspective for Cell Dissociation by Product Type - Percentage Breakdown of Value Sales for Enzymatic Dissociation Products, Non-enzymatic Dissociation Products and Instruments & Accessories for the Years 2020 & 2027
  • Table 91: Rest of World Current & Future Analysis for Cell Dissociation by Tissue - Connective Tissue, Epithelial Tissue and Other Tissue - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 92: Rest of World 7-Year Perspective for Cell Dissociation by Tissue - Percentage Breakdown of Value Sales for Connective Tissue, Epithelial Tissue and Other Tissue for the Years 2020 & 2027
  • Table 93: Rest of World Current & Future Analysis for Cell Dissociation by End-Use - Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 94: Rest of World 7-Year Perspective for Cell Dissociation by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnological Companies, Research & Academic Institutes and Other End-Uses for the Years 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 44
Note: Product cover images may vary from those shown
Adroll
adroll